Experimental cell therapy aims to boost chemo's punch against stubborn cancers
NCT ID NCT07356856
First seen Jan 23, 2026 · Last updated May 17, 2026 · Updated 25 times
Summary
This early-stage study tests a procedure called microtransplantation, where donor immune cells are given alongside chemotherapy to people with advanced or relapsed solid tumors. The main goals are to check safety and see how well the combination controls the cancer. Only 10 participants will be enrolled, and the study is not yet recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED AND RELAPSED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Innovvy(Beijing) Biomedical Technology Co., Ltd
Haidian, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Minzu Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First People's Hospital of Nanning
Nanning, Guangxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.